top of page
Frankis Almaguel, MD, PhD
What is Theranostics?
-
Theranostics means personalized cancer treatment: targeted and effective.
-
Imaging - at the molecular level - provides specific and superior diagnosis.
-
Dramatically fewer side effects than alternative treatment options.
Introducing
Theranostics
-
Precision targeting: Focusing on cancer cells means less damage to healthy tissue.
-
Optimized care: treatment is customized, based on the specific type of tumor.
-
Elevated experience: Enjoy compassionate, client-focused attention from start to finish.
Dr. Almaguel's
Approach
-
Molecular imaging lights up the specific areas of cancer that lesser methods would have missed.
-
Customized treatments can be designed to maximize patient results.
-
Earlier intervention and detection dramatically improves outcomes.
Illuminating the
Invisible
Frankis Almaguel, MD, PhD
Frankis Almaguel, a Nuclear Oncologist at Loma Linda University Cancer Center, leads the Molecular Imaging and Therapeutics Program.
Specializing in prostate cancer, his expertise in Radiology, Nuclear Oncology, and Theranostics informs his cutting-edge patient care and research.
Alan Held underwent a groundbreaking theranostics treatment for prostate cancer in Germany. This innovative approach, led by Dr. Frankis Almaguel at Loma Linda University Medical Center, eradicated 80% of Held's cancer cells after just one session. With thousands benefiting from theranostics in Germany, the FDA is on the brink of its use in the U.S., signaling a transformative shift in prostate cancer care.
Courtesy of the OC Register
Breakthrough in Prostate Cancer Treatment
theragnostics
bottom of page